• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国帕金森病死亡率分析:近期及未来趋势探索

Analysis of mortality in Parkinson disease in China: Exploration of recent and future trends.

作者信息

Lan Jinxin, Ren Yifan, Song Ge, Liu Lu, Li Mingyu, Zhang Renmu, Yin Chunyu, Zhou Hua, Zhang Xiangyuan, Lv Bin, Ma Yaqi

机构信息

The First Medical Center Chinese PLA General Hospital Beijing China.

School of Medicine Nankai University Tianjin China.

出版信息

Aging Med (Milton). 2024 Aug 19;7(4):490-498. doi: 10.1002/agm2.12354. eCollection 2024 Aug.

DOI:10.1002/agm2.12354
PMID:39234200
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11369336/
Abstract

OBJECTIVES

Parkinson disease (PD) is the third leading cause of mortality among middle-aged and older individuals in China. This study aimed to explore the trends and distribution features of PD mortality in China from 2013 to 2021 and make predictions for the next few decades.

METHODS

Relevant data were obtained from the Chinese Center for Disease Control and Prevention Disease Surveillance Point system. The joinpoint regression model was used to evaluate trends. The R software was used to predict future trends.

RESULTS

Age-standardized mortality rate (ASMR) of PD increased from 0.59 per 100,000 individuals to 1.22 per 100,000 individuals from 2013 to 2021, with an average annual percent change (AAPC) of 9.50 (95% CI: 8.24-10.78). The all-age ASMR of PD were higher in male individuals than in female individuals, and ASMR increased with age. The number of deaths and ASMR increased gradually from west to east and from rural to urban areas. Furthermore, ASMR is expected to increase to 2.66 per 100,000 individuals by 2040.

CONCLUSIONS

The heightened focus on the ASMR of PD among male individuals, urban areas, eastern China, and individuals aged ≥85 years has become a key determinant in further decreasing mortality, thereby exhibiting novel challenges to effective strategies for disease prevention and control.

摘要

目的

帕金森病(PD)是中国中老年人群中第三大死亡原因。本研究旨在探讨2013年至2021年中国PD死亡率的趋势和分布特征,并对未来几十年进行预测。

方法

相关数据来自中国疾病预防控制中心疾病监测点系统。采用Joinpoint回归模型评估趋势。使用R软件预测未来趋势。

结果

2013年至2021年,PD的年龄标准化死亡率(ASMR)从每10万人0.59例增加到每10万人1.22例,平均年变化百分比(AAPC)为9.50(95%CI:8.24-10.78)。PD的全年龄ASMR男性高于女性,且ASMR随年龄增长而增加。死亡人数和ASMR从西部到东部、从农村到城市地区逐渐增加。此外,预计到2040年,ASMR将增至每10万人2.66例。

结论

对男性、城市地区、中国东部以及年龄≥85岁人群中PD的ASMR的高度关注已成为进一步降低死亡率的关键决定因素,从而对有效的疾病预防和控制策略构成新挑战。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad5d/11369336/a4cff8e8f718/AGM2-7-490-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad5d/11369336/8e252cee1a99/AGM2-7-490-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad5d/11369336/219b4d797929/AGM2-7-490-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad5d/11369336/ee30358e1652/AGM2-7-490-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad5d/11369336/a4cff8e8f718/AGM2-7-490-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad5d/11369336/8e252cee1a99/AGM2-7-490-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad5d/11369336/219b4d797929/AGM2-7-490-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad5d/11369336/ee30358e1652/AGM2-7-490-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad5d/11369336/a4cff8e8f718/AGM2-7-490-g002.jpg

相似文献

1
Analysis of mortality in Parkinson disease in China: Exploration of recent and future trends.中国帕金森病死亡率分析:近期及未来趋势探索
Aging Med (Milton). 2024 Aug 19;7(4):490-498. doi: 10.1002/agm2.12354. eCollection 2024 Aug.
2
Mortality of Alzheimer's Disease and Other Dementias in China: Past and Future Decades.中国阿尔茨海默病和其他类型痴呆的死亡率:过去和未来几十年。
Int J Public Health. 2023 Feb 3;68:1605129. doi: 10.3389/ijph.2023.1605129. eCollection 2023.
3
Trends in Cause-Specific Injury Mortality in China in 2005-2019: Longitudinal Observational Study.2005-2019 年中国特定病因伤害死亡率的变化趋势:纵向观察研究。
JMIR Public Health Surveill. 2023 Sep 15;9:e47902. doi: 10.2196/47902.
4
Liver cancer in China: the analysis of mortality and burden of disease trends from 2008 to 2021.中国肝癌:2008 年至 2021 年死亡率和疾病负担趋势分析。
BMC Cancer. 2024 May 16;24(1):594. doi: 10.1186/s12885-024-12334-2.
5
Trends in parkinson's disease mortality in China from 2004 to 2021: a joinpoint analysis.中国帕金森病死亡率趋势分析(2004 年至 2021 年):联合分析
BMC Public Health. 2024 Apr 19;24(1):1091. doi: 10.1186/s12889-024-18532-8.
6
Trends of the burden of type 2 diabetes mellitus attributable to high body mass index from 1990 to 2019 in China.中国 1990 年至 2019 年归因于高身体质量指数的 2 型糖尿病负担趋势。
Front Endocrinol (Lausanne). 2023 May 31;14:1193884. doi: 10.3389/fendo.2023.1193884. eCollection 2023.
7
[Analysis and prediction of epidemiological characteristics of tuberculosis deaths among Chinese residents from 2006 to 2021].2006至2021年中国居民结核病死亡流行病学特征分析与预测
Zhonghua Liu Xing Bing Xue Za Zhi. 2024 Jun 10;45(6):824-832. doi: 10.3760/cma.j.cn112338-20231114-00286.
8
The trends of mental disorders mortality in China over a 33-year period.中国精神障碍死亡率 33 年趋势变化
Asian J Psychiatr. 2024 May;95:103996. doi: 10.1016/j.ajp.2024.103996. Epub 2024 Mar 7.
9
Thyroid cancer trends in China and its comparative analysis with G20 countries: Projections for 2020-2040.中国甲状腺癌趋势及其与 G20 国家的对比分析:2020-2040 年预测。
J Glob Health. 2024 Jun 14;14:04131. doi: 10.7189/jogh.14.04131.
10
[Chronic and non-communicable disease mortality and trends in Chinese elderly, 2004-2018].[2004 - 2018年中国老年人慢性非传染性疾病死亡率及趋势]
Zhonghua Liu Xing Bing Xue Za Zhi. 2021 Mar 10;42(3):499-507. doi: 10.3760/cma.j.cn112338-20200208-00079.

本文引用的文献

1
Social isolation and the risk of Parkinson disease in the UK biobank study.英国生物银行研究中的社会隔离与帕金森病风险
NPJ Parkinsons Dis. 2024 Apr 8;10(1):79. doi: 10.1038/s41531-024-00700-7.
2
Association between a body shape index and Parkinson's disease: A large cross-sectional study from NHANES.身体形态指数与帕金森病之间的关联:来自美国国家健康与营养检查调查(NHANES)的一项大型横断面研究。
Heliyon. 2024 Feb 19;10(4):e26557. doi: 10.1016/j.heliyon.2024.e26557. eCollection 2024 Feb 29.
3
Role of the Exposome in Neurodegenerative Disease: Recent Insights and Future Directions.
外显子组在神经退行性疾病中的作用:最新见解和未来方向。
Ann Neurol. 2024 Apr;95(4):635-652. doi: 10.1002/ana.26897. Epub 2024 Feb 27.
4
Exploiting macro- and micro-structural brain changes for improved Parkinson's disease classification from MRI data.利用大脑的宏观和微观结构变化,通过磁共振成像(MRI)数据改进帕金森病的分类。
NPJ Parkinsons Dis. 2024 Feb 26;10(1):43. doi: 10.1038/s41531-024-00647-9.
5
The Role of the Vascular System in Degenerative Diseases: Mechanisms and Implications.血管系统在退行性疾病中的作用:机制与意义。
Int J Mol Sci. 2024 Feb 11;25(4):2169. doi: 10.3390/ijms25042169.
6
Ageing with Parkinson's: Identification of Personal Needs in the Northern Spanish Context.帕金森病与衰老:西班牙北部地区个人需求的识别
Healthcare (Basel). 2024 Feb 19;12(4):498. doi: 10.3390/healthcare12040498.
7
The Potentiality of Natural Products and Herbal Medicine as Novel Medications for Parkinson's Disease: A Promising Therapeutic Approach.天然产物和草药作为帕金森病新型药物的潜力:一种有前途的治疗方法。
Int J Mol Sci. 2024 Jan 15;25(2):1071. doi: 10.3390/ijms25021071.
8
Update: Descriptive epidemiology of Parkinson disease.更新:帕金森病的描述性流行病学。
Parkinsonism Relat Disord. 2024 Mar;120:106000. doi: 10.1016/j.parkreldis.2024.106000. Epub 2024 Jan 8.
9
Increasing Parkinson's disease related mortality through the pandemic and beyond: An update.帕金森病相关死亡率在大流行期间及之后持续上升:最新情况。
Parkinsonism Relat Disord. 2024 Mar;120:105992. doi: 10.1016/j.parkreldis.2024.105992. Epub 2024 Jan 5.
10
Economic Burden of Parkinson's Disease: A Multinational, Real-World, Cost-of-Illness Study.帕金森病的经济负担:一项跨国、基于真实世界的疾病成本研究。
Drugs Real World Outcomes. 2024 Mar;11(1):1-11. doi: 10.1007/s40801-023-00410-1. Epub 2024 Jan 9.